From the Centers for Disease Control and Prevention. Impact of the 1999 AAP/USPHS Joint Statement on Thimerosal in Vaccines on Infant Hepatitis B Vaccination Practices. American Academy of Pediatrics/U.S. Public Health Service.
D006509:Hepatitis B / Q000517:prevention & control; D017325:Hepatitis B Vaccines / Q000008:administration & dosage / Q000600:supply & distribution; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008824:Michigan; D009825:Oklahoma; D009922:Oregon; D011310:Preservatives, Pharmaceutical; D013849:Thimerosal; D014611:Vaccination / Q000592:standards* / Q000706:statistics & numerical data; D014922:Wisconsin
D017325:Hepatitis B Vaccines; D011310:Preservatives, Pharmaceutical; D013849:Thimerosal